🦊/Lists

Biotech Investors & VC Firms in United States

1265 firms in this list, with a median first check of $500K. 278 of them lead rounds. Generated from verified public data and updated continuously.

Frazier Healthcare Partners
SeattleGrowth$50M – $400M
51 people
Playground Global
Palo AltoPre-Seed–Series A$1M – $20M
48 people
VU Venture Partners
San FranciscoSeed–Series B$200K – $1M
40 people
Bain Capital Life Sciences
BostonSeries B–Late Stage
47 people
HOF Capital
New YorkPre-Seed–Growth$25K – $15M
39 people
Advent International
BostonSeries A–Late Stage$1.1B
62 people
HLM Venture Partners
BostonSeed–Late Stage$3M – $5M
33 people
TPG
San FranciscoGrowth–Late Stage
53 people
Stifel Venture Banking
St. LouisSeed–Late Stage
75 people
Hatteras Venture Partners
Research TriangleSeed–Series C$500K – $4M
27 people
Atlas Venture
CambridgeSeed–Late Stage$500K – $1M
29 people
Sixth Street
San FranciscoPre-Seed–Late Stage$50M – $2.5B
44 people
MPM BioImpact
BostonPre-Seed–Late Stage$1M – $15M
50 people
Celesta Capital
Menlo ParkSeed–Late Stage$5M – $20M
33 people
Big Idea Ventures
New YorkPre-Seed–Seed$125K – $2.5M
14 people
Pear VC
San FranciscoPre-Seed–Series A$150K – $4M
28 people
Premji Invest
Menlo ParkSeed–Late Stage
35 people
Fifty Years
San FranciscoPre-Seed–Seed$250K – $2M
18 people
Anzu Partners
BillericaPre-Seed–Growth
49 people
Longwood Fund
BostonSeed–Series B
47 people
Basecamp Fund
ManchesterPre-Seed–Late Stage$100K – $10M
12 people
TEDCO
ColumbiaPre-Seed–Series B
8 people
Catalio Capital Management, LP
New YorkSeed–Late Stage
36 people
Hercules Capital, Inc.
San MateoSeed–Late Stage$5M – $500M
56 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.